TEIJIN REGENET

Serial Number 98018285
732

Registration Progress

Application Filed
May 30, 2023
Under Examination
Dec 12, 2023
Approved for Publication
Oct 17, 2023
Published for Opposition
Oct 17, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 3 Granted
Due: Dec 12, 2025 105 days

Trademark Image

TEIJIN REGENET

Basic Information

Serial Number
98018285
Filing Date
May 30, 2023
Published for Opposition
October 17, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
May 15, 2025
Application
Pending
Classes
040 042 044

Rights Holder

Teijin Kabushiki Kaisha (Teijin Limited)

03
Address
2-4, Nakanoshima 3-chome, Kita-ku
Osaka, Tokyo 530-0005
JP

Ownership History

Teijin Kabushiki Kaisha (Teijin Limited)

Original Applicant
03
Osaka, Tokyo JP

Teijin Kabushiki Kaisha (Teijin Limited)

Owner at Publication
03
Osaka, Tokyo JP

Legal Representation

Attorney
LEIGH ANN LINDQUIST

USPTO Deadlines

Next Deadline
105 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
December 12, 2025
Extension Available
Until December 12, 2024

Application History

26 events
Date Code Type Description Documents
May 16, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 15, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 15, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
May 15, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 3, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 3, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 18, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 18, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
May 15, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 14, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 14, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 14, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 12, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 17, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 27, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 8, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 8, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 8, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 8, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Sep 8, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 28, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 29, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 5, 2023 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Jun 2, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 040
Custom manufacture of pharmaceuticals; custom manufacture of cells; custom manufacture of biological tissue cultures; custom manufacture of cell culture medium; custom manufacture of medical apparatus; custom production of structures made of cells; custom processing of cells; consultancy relating to the manufacture of cells; providing information relating to the manufacture of cells; processing of cells used for cell therapy medicine
Class 042
Cell culture services for others for scientific and medical research purposes; testing, inspection, research and development of cells and tissue cultures for scientific and medical research purposes; advice, consultancy and providing information relating to testing, inspection, research or development of cells and tissue culture for scientific and medical research purposes; consultancy relating to cell culture and tissue culture for medical research purposes; culture and separation of cells and biological tissue for medical research purposes; consultancy and providing information relating to testing, inspection and research of pharmaceuticals; research and product development of cells; blood analysis services for scientific research purposes; scientific services relating to the isolation and cultivation of human tissues and cells; stem cell research; technological research in the fields of stem cells and tissue culturing; scientific research and development; consultancy and advising relating to culturing of cells
Class 044
Pharmaceutical consultancy; provision of medical information; advisory, consultancy and information services relating to medical care and regenerative medicine; human tissue bank services; cultured cell bank services for medical transplantation; separation, collection and preservation of blood components for medical purpose

Classification

International Classes
040 042 044